Figure 2.
Changes in FVC and DLco for each group over a 12-month period. (A) Changes in FVC % predicted over 12 months for each pirfenidone group. (B) Changes in DLco % predicted over 12 months for each pirfenidone group. FVC, forced vital capacity; DLco, diffusing capacity of the lung for carbon monoxide.